English
Segment disclosures
Company overviewCalumet, Inc. /DE
Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.
Revenue · Reported segment facts
Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.
Calumet Specialty Products Partners L.p. · Operating Segments · Montana Renewables
Legal Entity · Consolidation Items · Statement Business Segments
Source dimensions
dei:LegalEntityAxis=clmt:CalumetSpecialtyProductsPartnersL.p.Member;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=clmt:MontanaRenewablesMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-04-01 – 2024-06-30 | 291400000 | USD | 20240809 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 535900000 | USD | 20240809 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 248200000 | USD | 20240809 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 468000000 | USD | 20240809 | Open filing evidence |
Calumet Specialty Products Partners L.p. · Operating Segments · Montana Renewables · Sales Revenue Segment
Legal Entity · Consolidation Items · Statement Business Segments · Subsegments Consolidation Items
Source dimensions
dei:LegalEntityAxis=clmt:CalumetSpecialtyProductsPartnersL.p.Member;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=clmt:MontanaRenewablesMember;us-gaap:SubsegmentsConsolidationItemsAxis=us-gaap:SalesRevenueSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-04-01 – 2024-06-30 | 291400000 | USD | 20240809 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 535900000 | USD | 20240809 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 248200000 | USD | 20240809 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 468000000 | USD | 20240809 | Open filing evidence |
Calumet Specialty Products Partners L.p. · Operating Segments · Performance Brands
Legal Entity · Consolidation Items · Statement Business Segments
Source dimensions
dei:LegalEntityAxis=clmt:CalumetSpecialtyProductsPartnersL.p.Member;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=clmt:PerformanceBrandsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-04-01 – 2024-06-30 | 96200000 | USD | 20240809 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 176000000 | USD | 20240809 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 85600000 | USD | 20240809 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 164400000 | USD | 20240809 | Open filing evidence |
Calumet Specialty Products Partners L.p. · Operating Segments · Performance Brands · Intersubsegment Eliminations
Legal Entity · Consolidation Items · Statement Business Segments · Subsegments Consolidation Items
Source dimensions
dei:LegalEntityAxis=clmt:CalumetSpecialtyProductsPartnersL.p.Member;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=clmt:PerformanceBrandsMember;us-gaap:SubsegmentsConsolidationItemsAxis=us-gaap:IntersubsegmentEliminationsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-04-01 – 2024-06-30 | 100000 | USD | 20240809 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 200000 | USD | 20240809 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 100000 | USD | 20240809 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 100000 | USD | 20240809 | Open filing evidence |
Calumet Specialty Products Partners L.p. · Operating Segments · Performance Brands · Sales Revenue Segment
Legal Entity · Consolidation Items · Statement Business Segments · Subsegments Consolidation Items
Source dimensions
dei:LegalEntityAxis=clmt:CalumetSpecialtyProductsPartnersL.p.Member;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=clmt:PerformanceBrandsMember;us-gaap:SubsegmentsConsolidationItemsAxis=us-gaap:SalesRevenueSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-04-01 – 2024-06-30 | 96100000 | USD | 20240809 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 175800000 | USD | 20240809 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 85500000 | USD | 20240809 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 164300000 | USD | 20240809 | Open filing evidence |
Calumet Specialty Products Partners L.p. · Operating Segments · Specialty Products And Solutions
Legal Entity · Consolidation Items · Statement Business Segments
Source dimensions
dei:LegalEntityAxis=clmt:CalumetSpecialtyProductsPartnersL.p.Member;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=clmt:SpecialtyProductsAndSolutionsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-04-01 – 2024-06-30 | 753200000 | USD | 20240809 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 1439800000 | USD | 20240809 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 689300000 | USD | 20240809 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 1433400000 | USD | 20240809 | Open filing evidence |
Calumet Specialty Products Partners L.p. · Operating Segments · Specialty Products And Solutions · Intersubsegment Eliminations
Legal Entity · Consolidation Items · Statement Business Segments · Subsegments Consolidation Items
Source dimensions
dei:LegalEntityAxis=clmt:CalumetSpecialtyProductsPartnersL.p.Member;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=clmt:SpecialtyProductsAndSolutionsMember;us-gaap:SubsegmentsConsolidationItemsAxis=us-gaap:IntersubsegmentEliminationsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-04-01 – 2024-06-30 | 7000000 | USD | 20240809 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 12000000 | USD | 20240809 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 5200000 | USD | 20240809 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 10600000 | USD | 20240809 | Open filing evidence |
Calumet Specialty Products Partners L.p. · Operating Segments · Specialty Products And Solutions · Sales Revenue Segment
Legal Entity · Consolidation Items · Statement Business Segments · Subsegments Consolidation Items
Source dimensions
dei:LegalEntityAxis=clmt:CalumetSpecialtyProductsPartnersL.p.Member;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=clmt:SpecialtyProductsAndSolutionsMember;us-gaap:SubsegmentsConsolidationItemsAxis=us-gaap:SalesRevenueSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-04-01 – 2024-06-30 | 746200000 | USD | 20240809 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 1427800000 | USD | 20240809 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 684100000 | USD | 20240809 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 1422800000 | USD | 20240809 | Open filing evidence |
Calumet Specialty Products Partners L.p. · Asphalt Heavy Fuel Oils And Other · Sales · Product Concentration Risk · Montana Renewables
Legal Entity · Product Or Service · Concentration Risk By Benchmark · Concentration Risk By Type · Statement Business Segments
Source dimensions
dei:LegalEntityAxis=clmt:CalumetSpecialtyProductsPartnersL.p.Member;srt:ProductOrServiceAxis=clmt:AsphaltHeavyFuelOilsAndOtherMember;us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:SalesMember;us-gaap:ConcentrationRiskByTypeAxis=us-gaap:ProductConcentrationRiskMember;us-gaap:StatementBusinessSegmentsAxis=clmt:MontanaRenewablesMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-04-01 – 2024-06-30 | 37100000 | USD | 20240809 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 67200000 | USD | 20240809 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 37800000 | USD | 20240809 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 58300000 | USD | 20240809 | Open filing evidence |
Calumet Specialty Products Partners L.p. · Diesel · Sales · Product Concentration Risk · Montana Renewables
Legal Entity · Product Or Service · Concentration Risk By Benchmark · Concentration Risk By Type · Statement Business Segments
Source dimensions
dei:LegalEntityAxis=clmt:CalumetSpecialtyProductsPartnersL.p.Member;srt:ProductOrServiceAxis=clmt:DieselMember;us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:SalesMember;us-gaap:ConcentrationRiskByTypeAxis=us-gaap:ProductConcentrationRiskMember;us-gaap:StatementBusinessSegmentsAxis=clmt:MontanaRenewablesMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-04-01 – 2024-06-30 | 29000000 | USD | 20240809 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 56900000 | USD | 20240809 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 35900000 | USD | 20240809 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 68800000 | USD | 20240809 | Open filing evidence |
Calumet Specialty Products Partners L.p. · Gasoline · Sales · Product Concentration Risk · Montana Renewables
Legal Entity · Product Or Service · Concentration Risk By Benchmark · Concentration Risk By Type · Statement Business Segments
Source dimensions
dei:LegalEntityAxis=clmt:CalumetSpecialtyProductsPartnersL.p.Member;srt:ProductOrServiceAxis=clmt:GasolineMember;us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:SalesMember;us-gaap:ConcentrationRiskByTypeAxis=us-gaap:ProductConcentrationRiskMember;us-gaap:StatementBusinessSegmentsAxis=clmt:MontanaRenewablesMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-04-01 – 2024-06-30 | 37600000 | USD | 20240809 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 69200000 | USD | 20240809 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 40700000 | USD | 20240809 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 83600000 | USD | 20240809 | Open filing evidence |
Calumet Specialty Products Partners L.p. · Jet Fuel · Sales · Product Concentration Risk · Montana Renewables
Legal Entity · Product Or Service · Concentration Risk By Benchmark · Concentration Risk By Type · Statement Business Segments
Source dimensions
dei:LegalEntityAxis=clmt:CalumetSpecialtyProductsPartnersL.p.Member;srt:ProductOrServiceAxis=clmt:JetFuelMember;us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:SalesMember;us-gaap:ConcentrationRiskByTypeAxis=us-gaap:ProductConcentrationRiskMember;us-gaap:StatementBusinessSegmentsAxis=clmt:MontanaRenewablesMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-04-01 – 2024-06-30 | 4900000 | USD | 20240809 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 9500000 | USD | 20240809 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 5600000 | USD | 20240809 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 10500000 | USD | 20240809 | Open filing evidence |
Calumet Specialty Products Partners L.p. · Lubricating Oils · Sales · Product Concentration Risk · Specialty Products And Solutions
Legal Entity · Product Or Service · Concentration Risk By Benchmark · Concentration Risk By Type · Statement Business Segments
Source dimensions
dei:LegalEntityAxis=clmt:CalumetSpecialtyProductsPartnersL.p.Member;srt:ProductOrServiceAxis=clmt:LubricatingOilsMember;us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:SalesMember;us-gaap:ConcentrationRiskByTypeAxis=us-gaap:ProductConcentrationRiskMember;us-gaap:StatementBusinessSegmentsAxis=clmt:SpecialtyProductsAndSolutionsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-04-01 – 2024-06-30 | 215900000 | USD | 20240809 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 405600000 | USD | 20240809 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 186300000 | USD | 20240809 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 401400000 | USD | 20240809 | Open filing evidence |
Calumet Specialty Products Partners L.p. · Other Specialty Products · Sales · Product Concentration Risk · Specialty Products And Solutions
Legal Entity · Product Or Service · Concentration Risk By Benchmark · Concentration Risk By Type · Statement Business Segments
Source dimensions
dei:LegalEntityAxis=clmt:CalumetSpecialtyProductsPartnersL.p.Member;srt:ProductOrServiceAxis=clmt:OtherSpecialtyProductsMember;us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:SalesMember;us-gaap:ConcentrationRiskByTypeAxis=us-gaap:ProductConcentrationRiskMember;us-gaap:StatementBusinessSegmentsAxis=clmt:SpecialtyProductsAndSolutionsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-04-01 – 2024-06-30 | 380700000 | USD | 20240809 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 731200000 | USD | 20240809 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 361400000 | USD | 20240809 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 734200000 | USD | 20240809 | Open filing evidence |
Calumet Specialty Products Partners L.p. · Renewable Fuels · Sales · Product Concentration Risk · Montana Renewables
Legal Entity · Product Or Service · Concentration Risk By Benchmark · Concentration Risk By Type · Statement Business Segments
Source dimensions
dei:LegalEntityAxis=clmt:CalumetSpecialtyProductsPartnersL.p.Member;srt:ProductOrServiceAxis=clmt:RenewableFuelsMember;us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:SalesMember;us-gaap:ConcentrationRiskByTypeAxis=us-gaap:ProductConcentrationRiskMember;us-gaap:StatementBusinessSegmentsAxis=clmt:MontanaRenewablesMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-04-01 – 2024-06-30 | 182800000 | USD | 20240809 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 333100000 | USD | 20240809 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 128200000 | USD | 20240809 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 246800000 | USD | 20240809 | Open filing evidence |
Calumet Specialty Products Partners L.p. · Solvents · Sales · Product Concentration Risk · Specialty Products And Solutions
Legal Entity · Product Or Service · Concentration Risk By Benchmark · Concentration Risk By Type · Statement Business Segments
Source dimensions
dei:LegalEntityAxis=clmt:CalumetSpecialtyProductsPartnersL.p.Member;srt:ProductOrServiceAxis=clmt:SolventsMember;us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:SalesMember;us-gaap:ConcentrationRiskByTypeAxis=us-gaap:ProductConcentrationRiskMember;us-gaap:StatementBusinessSegmentsAxis=clmt:SpecialtyProductsAndSolutionsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-04-01 – 2024-06-30 | 109500000 | USD | 20240809 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 211900000 | USD | 20240809 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 96200000 | USD | 20240809 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 202800000 | USD | 20240809 | Open filing evidence |
Calumet Specialty Products Partners L.p. · Waxes · Sales · Product Concentration Risk · Specialty Products And Solutions
Legal Entity · Product Or Service · Concentration Risk By Benchmark · Concentration Risk By Type · Statement Business Segments
Source dimensions
dei:LegalEntityAxis=clmt:CalumetSpecialtyProductsPartnersL.p.Member;srt:ProductOrServiceAxis=clmt:WaxesMember;us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:SalesMember;us-gaap:ConcentrationRiskByTypeAxis=us-gaap:ProductConcentrationRiskMember;us-gaap:StatementBusinessSegmentsAxis=clmt:SpecialtyProductsAndSolutionsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-04-01 – 2024-06-30 | 40100000 | USD | 20240809 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 79100000 | USD | 20240809 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 40200000 | USD | 20240809 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 84400000 | USD | 20240809 | Open filing evidence |
Calumet Specialty Products Partners L.p. · Sales · Product Concentration Risk · Montana Renewables
Legal Entity · Concentration Risk By Benchmark · Concentration Risk By Type · Statement Business Segments
Source dimensions
dei:LegalEntityAxis=clmt:CalumetSpecialtyProductsPartnersL.p.Member;us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:SalesMember;us-gaap:ConcentrationRiskByTypeAxis=us-gaap:ProductConcentrationRiskMember;us-gaap:StatementBusinessSegmentsAxis=clmt:MontanaRenewablesMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-04-01 – 2024-06-30 | 291400000 | USD | 20240809 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 535900000 | USD | 20240809 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 248200000 | USD | 20240809 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 468000000 | USD | 20240809 | Open filing evidence |
Calumet Specialty Products Partners L.p. · Sales · Product Concentration Risk · Performance Brands
Legal Entity · Concentration Risk By Benchmark · Concentration Risk By Type · Statement Business Segments
Source dimensions
dei:LegalEntityAxis=clmt:CalumetSpecialtyProductsPartnersL.p.Member;us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:SalesMember;us-gaap:ConcentrationRiskByTypeAxis=us-gaap:ProductConcentrationRiskMember;us-gaap:StatementBusinessSegmentsAxis=clmt:PerformanceBrandsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-04-01 – 2024-06-30 | 96100000 | USD | 20240809 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 175800000 | USD | 20240809 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 85500000 | USD | 20240809 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 164300000 | USD | 20240809 | Open filing evidence |
Calumet Specialty Products Partners L.p. · Sales · Product Concentration Risk · Specialty Products And Solutions
Legal Entity · Concentration Risk By Benchmark · Concentration Risk By Type · Statement Business Segments
Source dimensions
dei:LegalEntityAxis=clmt:CalumetSpecialtyProductsPartnersL.p.Member;us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:SalesMember;us-gaap:ConcentrationRiskByTypeAxis=us-gaap:ProductConcentrationRiskMember;us-gaap:StatementBusinessSegmentsAxis=clmt:SpecialtyProductsAndSolutionsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-04-01 – 2024-06-30 | 746200000 | USD | 20240809 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 1427800000 | USD | 20240809 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 684100000 | USD | 20240809 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 1422800000 | USD | 20240809 | Open filing evidence |
Operating Segments · Montana Renewables
Consolidation Items · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=clmt:MontanaRenewablesMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-01-01 – 2026-03-31 | 235800000 | USD | 20260508 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 1193100000 | USD | 20260227 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 319200000 | USD | 20251110 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 898900000 | USD | 20251110 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 318000000 | USD | 20251110 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 579700000 | USD | 20251110 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 261700000 | USD | 20260508 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 1064900000 | USD | 20260227 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 306100000 | USD | 20251110 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 842000000 | USD | 20251110 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 291400000 | USD | 20251110 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 535900000 | USD | 20251110 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 244500000 | USD | 20251110 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 993800000 | USD | 20260227 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 328500000 | USD | 20241112 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 796500000 | USD | 20241112 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 874900000 | USD | 20250303 | Open filing evidence |
Operating Segments · Montana Renewables · Intersubsegment Eliminations
Consolidation Items · Statement Business Segments · Subsegments Consolidation Items
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=clmt:MontanaRenewablesMember;us-gaap:SubsegmentsConsolidationItemsAxis=us-gaap:IntersubsegmentEliminationsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-01-01 – 2024-12-31 | 0 | USD | 20250303 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 0 | USD | 20250303 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 0 | USD | 20250303 | Open filing evidence |
Operating Segments · Montana Renewables · Sales Revenue Segment
Consolidation Items · Statement Business Segments · Subsegments Consolidation Items
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=clmt:MontanaRenewablesMember;us-gaap:SubsegmentsConsolidationItemsAxis=us-gaap:SalesRevenueSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-01-01 – 2026-03-31 | 235800000 | USD | 20260508 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 1193100000 | USD | 20260227 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 319200000 | USD | 20251110 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 898900000 | USD | 20251110 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 318000000 | USD | 20251110 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 579700000 | USD | 20251110 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 261700000 | USD | 20260508 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 1064900000 | USD | 20260227 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 306100000 | USD | 20251110 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 842000000 | USD | 20251110 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 291400000 | USD | 20251110 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 535900000 | USD | 20251110 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 244500000 | USD | 20251110 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 993800000 | USD | 20260227 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 328500000 | USD | 20241112 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 796500000 | USD | 20241112 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 874900000 | USD | 20250303 | Open filing evidence |
Operating Segments · Montana Renewables Segment
Consolidation Items · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=clmt:MontanaRenewablesSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 329000000 | USD | 20260807 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 564900000 | USD | 20260807 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 318000000 | USD | 20260807 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 579700000 | USD | 20260807 | Open filing evidence |
Operating Segments · Performance Brands
Consolidation Items · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=clmt:PerformanceBrandsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-01-01 – 2026-03-31 | 89000000 | USD | 20260508 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 311500000 | USD | 20260227 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 79900000 | USD | 20251110 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 242800000 | USD | 20251110 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 80800000 | USD | 20251110 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 162900000 | USD | 20251110 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 82100000 | USD | 20260508 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 335600000 | USD | 20260227 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 80400000 | USD | 20251110 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 256400000 | USD | 20251110 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 96200000 | USD | 20251110 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 176000000 | USD | 20251110 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 79800000 | USD | 20251110 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 310600000 | USD | 20260227 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 75300000 | USD | 20241112 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 239700000 | USD | 20241112 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 303400000 | USD | 20250303 | Open filing evidence |
Operating Segments · Performance Brands · Intersubsegment Eliminations
Consolidation Items · Statement Business Segments · Subsegments Consolidation Items
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=clmt:PerformanceBrandsMember;us-gaap:SubsegmentsConsolidationItemsAxis=us-gaap:IntersubsegmentEliminationsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-01-01 – 2026-03-31 | 100000 | USD | 20260508 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 500000 | USD | 20260227 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 200000 | USD | 20251110 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 300000 | USD | 20251110 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 100000 | USD | 20251110 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 100000 | USD | 20251110 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 400000 | USD | 20260227 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 100000 | USD | 20251110 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 300000 | USD | 20251110 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 100000 | USD | 20251110 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 200000 | USD | 20251110 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 100000 | USD | 20251110 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 300000 | USD | 20260227 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 100000 | USD | 20241112 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 200000 | USD | 20241112 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 0 | USD | 20250303 | Open filing evidence |
Operating Segments · Performance Brands · Sales Revenue Segment
Consolidation Items · Statement Business Segments · Subsegments Consolidation Items
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=clmt:PerformanceBrandsMember;us-gaap:SubsegmentsConsolidationItemsAxis=us-gaap:SalesRevenueSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-01-01 – 2026-03-31 | 88900000 | USD | 20260508 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 311000000 | USD | 20260227 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 79700000 | USD | 20251110 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 242500000 | USD | 20251110 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 80700000 | USD | 20251110 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 162800000 | USD | 20251110 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 82100000 | USD | 20260508 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 335200000 | USD | 20260227 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 80300000 | USD | 20251110 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 256100000 | USD | 20251110 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 96100000 | USD | 20251110 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 175800000 | USD | 20251110 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 79700000 | USD | 20251110 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 310300000 | USD | 20260227 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 75200000 | USD | 20241112 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 239500000 | USD | 20241112 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 303400000 | USD | 20250303 | Open filing evidence |
Operating Segments · Performance Brands Segment
Consolidation Items · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=clmt:PerformanceBrandsSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 103600000 | USD | 20260807 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 192600000 | USD | 20260807 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 80800000 | USD | 20260807 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 162900000 | USD | 20260807 | Open filing evidence |
Operating Segments · Specialty Products And Solutions
Consolidation Items · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=clmt:SpecialtyProductsAndSolutionsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-01-01 – 2026-03-31 | 708900000 | USD | 20260508 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 2652400000 | USD | 20260227 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 684100000 | USD | 20251110 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 1972000000 | USD | 20251110 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 633000000 | USD | 20251110 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 1287900000 | USD | 20251110 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 654900000 | USD | 20260508 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 2812600000 | USD | 20260227 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 720300000 | USD | 20251110 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 2160100000 | USD | 20251110 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 753200000 | USD | 20251110 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 1439800000 | USD | 20251110 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 686600000 | USD | 20251110 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 2894100000 | USD | 20260227 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 748200000 | USD | 20241112 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 2181600000 | USD | 20241112 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 3532700000 | USD | 20250303 | Open filing evidence |
Operating Segments · Specialty Products And Solutions · Intersubsegment Eliminations
Consolidation Items · Statement Business Segments · Subsegments Consolidation Items
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=clmt:SpecialtyProductsAndSolutionsMember;us-gaap:SubsegmentsConsolidationItemsAxis=us-gaap:IntersubsegmentEliminationsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-01-01 – 2026-03-31 | 3900000 | USD | 20260508 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 19400000 | USD | 20260227 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 5000000 | USD | 20251110 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 14900000 | USD | 20251110 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 5100000 | USD | 20251110 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 9900000 | USD | 20251110 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 4800000 | USD | 20260508 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 23300000 | USD | 20260227 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 6300000 | USD | 20251110 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 18300000 | USD | 20251110 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 7000000 | USD | 20251110 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 12000000 | USD | 20251110 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 5000000 | USD | 20251110 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 17200000 | USD | 20260227 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 2500000 | USD | 20241112 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 13100000 | USD | 20241112 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 24700000 | USD | 20250303 | Open filing evidence |
Operating Segments · Specialty Products And Solutions · Sales Revenue Segment
Consolidation Items · Statement Business Segments · Subsegments Consolidation Items
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=clmt:SpecialtyProductsAndSolutionsMember;us-gaap:SubsegmentsConsolidationItemsAxis=us-gaap:SalesRevenueSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-01-01 – 2026-03-31 | 705000000 | USD | 20260508 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 2633000000 | USD | 20260227 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 679100000 | USD | 20251110 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 1957100000 | USD | 20251110 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 627900000 | USD | 20251110 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 1278000000 | USD | 20251110 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 650100000 | USD | 20260508 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 2789300000 | USD | 20260227 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 714000000 | USD | 20251110 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 2141800000 | USD | 20251110 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 746200000 | USD | 20251110 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 1427800000 | USD | 20251110 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 681600000 | USD | 20251110 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 2876900000 | USD | 20260227 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 745700000 | USD | 20241112 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 2168500000 | USD | 20241112 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 3508000000 | USD | 20250303 | Open filing evidence |
Operating Segments · Specialty Products And Solutions Segment
Consolidation Items · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=clmt:SpecialtyProductsAndSolutionsSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 1021500000 | USD | 20260807 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 1730400000 | USD | 20260807 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 633000000 | USD | 20260807 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 1287900000 | USD | 20260807 | Open filing evidence |
Operating Segments · Corporate
Consolidation Items · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=us-gaap:CorporateMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-01-01 – 2024-12-31 | 0 | USD | 20250303 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 0 | USD | 20250303 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 0 | USD | 20250303 | Open filing evidence |
Operating Segments · Corporate · Intersubsegment Eliminations
Consolidation Items · Statement Business Segments · Subsegments Consolidation Items
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=us-gaap:CorporateMember;us-gaap:SubsegmentsConsolidationItemsAxis=us-gaap:IntersubsegmentEliminationsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-01-01 – 2024-12-31 | 0 | USD | 20250303 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 0 | USD | 20250303 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 0 | USD | 20250303 | Open filing evidence |
Operating Segments · Corporate · Sales Revenue Segment
Consolidation Items · Statement Business Segments · Subsegments Consolidation Items
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=us-gaap:CorporateMember;us-gaap:SubsegmentsConsolidationItemsAxis=us-gaap:SalesRevenueSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-01-01 – 2024-12-31 | 0 | USD | 20250303 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 0 | USD | 20250303 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 0 | USD | 20250303 | Open filing evidence |
Asphalt Heavy Fuel Oils And Other · Sales · Product Concentration Risk · Montana Renewables
Product Or Service · Concentration Risk By Benchmark · Concentration Risk By Type · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=clmt:AsphaltHeavyFuelOilsAndOtherMember;us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:SalesMember;us-gaap:ConcentrationRiskByTypeAxis=us-gaap:ProductConcentrationRiskMember;us-gaap:StatementBusinessSegmentsAxis=clmt:MontanaRenewablesMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-01-01 – 2026-03-31 | 22800000 | USD | 20260508 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 159000000 | USD | 20260227 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 42900000 | USD | 20251110 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 123500000 | USD | 20251110 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 44600000 | USD | 20251110 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 80600000 | USD | 20251110 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 36000000 | USD | 20260508 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 159600000 | USD | 20260227 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 51300000 | USD | 20251110 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 118500000 | USD | 20251110 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 37100000 | USD | 20251110 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 67200000 | USD | 20251110 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 30100000 | USD | 20251110 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 148100000 | USD | 20260227 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 50200000 | USD | 20241112 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 108300000 | USD | 20241112 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 253200000 | USD | 20250303 | Open filing evidence |
Diesel · Sales · Product Concentration Risk · Montana Renewables
Product Or Service · Concentration Risk By Benchmark · Concentration Risk By Type · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=clmt:DieselMember;us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:SalesMember;us-gaap:ConcentrationRiskByTypeAxis=us-gaap:ProductConcentrationRiskMember;us-gaap:StatementBusinessSegmentsAxis=clmt:MontanaRenewablesMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-01-01 – 2026-03-31 | 31400000 | USD | 20260508 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 102600000 | USD | 20260227 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 29600000 | USD | 20251110 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 79400000 | USD | 20251110 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 26400000 | USD | 20251110 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 49800000 | USD | 20251110 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 23400000 | USD | 20260508 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 114600000 | USD | 20260227 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 31000000 | USD | 20251110 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 87900000 | USD | 20251110 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 29000000 | USD | 20251110 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 56900000 | USD | 20251110 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 27900000 | USD | 20251110 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 144800000 | USD | 20260227 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 39900000 | USD | 20241112 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 108700000 | USD | 20241112 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 391800000 | USD | 20250303 | Open filing evidence |
Gasoline · Sales · Product Concentration Risk · Montana Renewables
Product Or Service · Concentration Risk By Benchmark · Concentration Risk By Type · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=clmt:GasolineMember;us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:SalesMember;us-gaap:ConcentrationRiskByTypeAxis=us-gaap:ProductConcentrationRiskMember;us-gaap:StatementBusinessSegmentsAxis=clmt:MontanaRenewablesMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-01-01 – 2026-03-31 | 34600000 | USD | 20260508 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 128100000 | USD | 20260227 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 35800000 | USD | 20251110 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 101800000 | USD | 20251110 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 33500000 | USD | 20251110 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 66000000 | USD | 20251110 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 32500000 | USD | 20260508 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 140800000 | USD | 20260227 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 40800000 | USD | 20251110 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 110000000 | USD | 20251110 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 37600000 | USD | 20251110 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 69200000 | USD | 20251110 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 31600000 | USD | 20251110 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 167200000 | USD | 20260227 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 47900000 | USD | 20241112 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 131600000 | USD | 20241112 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 188100000 | USD | 20250303 | Open filing evidence |
Jet Fuel · Sales · Product Concentration Risk · Montana Renewables
Product Or Service · Concentration Risk By Benchmark · Concentration Risk By Type · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=clmt:JetFuelMember;us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:SalesMember;us-gaap:ConcentrationRiskByTypeAxis=us-gaap:ProductConcentrationRiskMember;us-gaap:StatementBusinessSegmentsAxis=clmt:MontanaRenewablesMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-01-01 – 2026-03-31 | 4800000 | USD | 20260508 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 19600000 | USD | 20260227 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 6500000 | USD | 20251110 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 15400000 | USD | 20251110 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 4700000 | USD | 20251110 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 8900000 | USD | 20251110 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 4200000 | USD | 20260508 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 18200000 | USD | 20260227 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 5300000 | USD | 20251110 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 14800000 | USD | 20251110 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 4900000 | USD | 20251110 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 9500000 | USD | 20251110 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 4600000 | USD | 20251110 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 20500000 | USD | 20260227 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 5900000 | USD | 20241112 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 16500000 | USD | 20241112 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 41800000 | USD | 20250303 | Open filing evidence |
Lubricating Oils · Sales · Product Concentration Risk · Specialty Products And Solutions
Product Or Service · Concentration Risk By Benchmark · Concentration Risk By Type · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=clmt:LubricatingOilsMember;us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:SalesMember;us-gaap:ConcentrationRiskByTypeAxis=us-gaap:ProductConcentrationRiskMember;us-gaap:StatementBusinessSegmentsAxis=clmt:SpecialtyProductsAndSolutionsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-01-01 – 2026-03-31 | 191800000 | USD | 20260508 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 752000000 | USD | 20260227 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 183500000 | USD | 20251110 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 576000000 | USD | 20251110 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 190300000 | USD | 20251110 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 392500000 | USD | 20251110 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 202200000 | USD | 20260508 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 788600000 | USD | 20260227 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 192500000 | USD | 20251110 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 598100000 | USD | 20251110 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 215900000 | USD | 20251110 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 405600000 | USD | 20251110 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 189700000 | USD | 20251110 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 763800000 | USD | 20260227 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 175800000 | USD | 20241112 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 577200000 | USD | 20241112 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 913700000 | USD | 20250303 | Open filing evidence |
Lubricating Oils · Product Concentration Risk · Revenue From Contract With Customer · Specialty Products And Solutions Segment
Product Or Service · Concentration Risk By Type · Concentration Risk By Benchmark · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=clmt:LubricatingOilsMember;us-gaap:ConcentrationRiskByTypeAxis=us-gaap:ProductConcentrationRiskMember;us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember;us-gaap:StatementBusinessSegmentsAxis=clmt:SpecialtyProductsAndSolutionsSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 281000000 | USD | 20260807 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 472800000 | USD | 20260807 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 190300000 | USD | 20260807 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 392500000 | USD | 20260807 | Open filing evidence |
Other Specialty Products · Sales · Product Concentration Risk · Specialty Products And Solutions
Product Or Service · Concentration Risk By Benchmark · Concentration Risk By Type · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=clmt:OtherSpecialtyProductsMember;us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:SalesMember;us-gaap:ConcentrationRiskByTypeAxis=us-gaap:ProductConcentrationRiskMember;us-gaap:StatementBusinessSegmentsAxis=clmt:SpecialtyProductsAndSolutionsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-01-01 – 2026-03-31 | 365500000 | USD | 20260508 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 1327000000 | USD | 20260227 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 360900000 | USD | 20251110 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 961800000 | USD | 20251110 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 295900000 | USD | 20251110 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 600900000 | USD | 20251110 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 305000000 | USD | 20260508 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 1437100000 | USD | 20260227 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 376600000 | USD | 20251110 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 1107800000 | USD | 20251110 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 380700000 | USD | 20251110 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 731200000 | USD | 20251110 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 350500000 | USD | 20251110 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 1550700000 | USD | 20260227 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 437700000 | USD | 20241112 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 1171900000 | USD | 20241112 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 1970100000 | USD | 20250303 | Open filing evidence |
Other Specialty Products · Product Concentration Risk · Revenue From Contract With Customer · Montana Renewables Segment
Product Or Service · Concentration Risk By Type · Concentration Risk By Benchmark · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=clmt:OtherSpecialtyProductsMember;us-gaap:ConcentrationRiskByTypeAxis=us-gaap:ProductConcentrationRiskMember;us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember;us-gaap:StatementBusinessSegmentsAxis=clmt:MontanaRenewablesSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 145800000 | USD | 20260807 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 239500000 | USD | 20260807 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 109200000 | USD | 20260807 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 205300000 | USD | 20260807 | Open filing evidence |
Other Specialty Products · Product Concentration Risk · Revenue From Contract With Customer · Specialty Products And Solutions Segment
Product Or Service · Concentration Risk By Type · Concentration Risk By Benchmark · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=clmt:OtherSpecialtyProductsMember;us-gaap:ConcentrationRiskByTypeAxis=us-gaap:ProductConcentrationRiskMember;us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember;us-gaap:StatementBusinessSegmentsAxis=clmt:SpecialtyProductsAndSolutionsSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 537400000 | USD | 20260807 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 902900000 | USD | 20260807 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 295900000 | USD | 20260807 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 600900000 | USD | 20260807 | Open filing evidence |
Renewable Fuels · Sales · Product Concentration Risk · Montana Renewables
Product Or Service · Concentration Risk By Benchmark · Concentration Risk By Type · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=clmt:RenewableFuelsMember;us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:SalesMember;us-gaap:ConcentrationRiskByTypeAxis=us-gaap:ProductConcentrationRiskMember;us-gaap:StatementBusinessSegmentsAxis=clmt:MontanaRenewablesMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-01-01 – 2026-03-31 | 142200000 | USD | 20260508 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 783800000 | USD | 20260227 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 204400000 | USD | 20251110 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 578800000 | USD | 20251110 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 208800000 | USD | 20251110 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 374400000 | USD | 20251110 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 165600000 | USD | 20260508 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 631700000 | USD | 20260227 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 177700000 | USD | 20251110 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 510800000 | USD | 20251110 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 182800000 | USD | 20251110 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 333100000 | USD | 20251110 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 150300000 | USD | 20251110 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 513200000 | USD | 20260227 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 184600000 | USD | 20241112 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 431400000 | USD | 20241112 | Open filing evidence |
Renewable Fuels · Product Concentration Risk · Revenue From Contract With Customer · Montana Renewables Segment
Product Or Service · Concentration Risk By Type · Concentration Risk By Benchmark · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=clmt:RenewableFuelsMember;us-gaap:ConcentrationRiskByTypeAxis=us-gaap:ProductConcentrationRiskMember;us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember;us-gaap:StatementBusinessSegmentsAxis=clmt:MontanaRenewablesSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 183200000 | USD | 20260807 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 325400000 | USD | 20260807 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 208800000 | USD | 20260807 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 374400000 | USD | 20260807 | Open filing evidence |
Solvents · Sales · Product Concentration Risk · Specialty Products And Solutions
Product Or Service · Concentration Risk By Benchmark · Concentration Risk By Type · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=clmt:SolventsMember;us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:SalesMember;us-gaap:ConcentrationRiskByTypeAxis=us-gaap:ProductConcentrationRiskMember;us-gaap:StatementBusinessSegmentsAxis=clmt:SpecialtyProductsAndSolutionsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-01-01 – 2026-03-31 | 107900000 | USD | 20260508 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 401600000 | USD | 20260227 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 97700000 | USD | 20251110 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 303900000 | USD | 20251110 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 101500000 | USD | 20251110 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 206200000 | USD | 20251110 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 104700000 | USD | 20260508 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 407300000 | USD | 20260227 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 106100000 | USD | 20251110 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 318000000 | USD | 20251110 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 109500000 | USD | 20251110 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 211900000 | USD | 20251110 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 102400000 | USD | 20251110 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 398500000 | USD | 20260227 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 92100000 | USD | 20241112 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 294900000 | USD | 20241112 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 434900000 | USD | 20250303 | Open filing evidence |
Solvents · Product Concentration Risk · Revenue From Contract With Customer · Specialty Products And Solutions Segment
Product Or Service · Concentration Risk By Type · Concentration Risk By Benchmark · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=clmt:SolventsMember;us-gaap:ConcentrationRiskByTypeAxis=us-gaap:ProductConcentrationRiskMember;us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember;us-gaap:StatementBusinessSegmentsAxis=clmt:SpecialtyProductsAndSolutionsSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 153200000 | USD | 20260807 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 261100000 | USD | 20260807 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 101500000 | USD | 20260807 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 206200000 | USD | 20260807 | Open filing evidence |
Waxes · Sales · Product Concentration Risk · Specialty Products And Solutions
Product Or Service · Concentration Risk By Benchmark · Concentration Risk By Type · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=clmt:WaxesMember;us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:SalesMember;us-gaap:ConcentrationRiskByTypeAxis=us-gaap:ProductConcentrationRiskMember;us-gaap:StatementBusinessSegmentsAxis=clmt:SpecialtyProductsAndSolutionsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-01-01 – 2026-03-31 | 39800000 | USD | 20260508 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 152400000 | USD | 20260227 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 37000000 | USD | 20251110 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 115400000 | USD | 20251110 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 40200000 | USD | 20251110 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 78400000 | USD | 20251110 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 38200000 | USD | 20260508 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 156300000 | USD | 20260227 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 38800000 | USD | 20251110 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 117900000 | USD | 20251110 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 40100000 | USD | 20251110 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 79100000 | USD | 20251110 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 39000000 | USD | 20251110 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 163900000 | USD | 20260227 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 40100000 | USD | 20241112 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 124500000 | USD | 20241112 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 189300000 | USD | 20250303 | Open filing evidence |
Waxes · Product Concentration Risk · Revenue From Contract With Customer · Specialty Products And Solutions Segment
Product Or Service · Concentration Risk By Type · Concentration Risk By Benchmark · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=clmt:WaxesMember;us-gaap:ConcentrationRiskByTypeAxis=us-gaap:ProductConcentrationRiskMember;us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember;us-gaap:StatementBusinessSegmentsAxis=clmt:SpecialtyProductsAndSolutionsSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 40900000 | USD | 20260807 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 80700000 | USD | 20260807 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 40200000 | USD | 20260807 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 78400000 | USD | 20260807 | Open filing evidence |
Sales · Product Concentration Risk · Montana Renewables
Concentration Risk By Benchmark · Concentration Risk By Type · Statement Business Segments
Source dimensions
us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:SalesMember;us-gaap:ConcentrationRiskByTypeAxis=us-gaap:ProductConcentrationRiskMember;us-gaap:StatementBusinessSegmentsAxis=clmt:MontanaRenewablesMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-01-01 – 2026-03-31 | 235800000 | USD | 20260508 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 1193100000 | USD | 20260227 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 319200000 | USD | 20251110 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 898900000 | USD | 20251110 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 318000000 | USD | 20251110 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 579700000 | USD | 20251110 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 261700000 | USD | 20260508 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 1064900000 | USD | 20260227 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 306100000 | USD | 20251110 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 842000000 | USD | 20251110 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 291400000 | USD | 20251110 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 535900000 | USD | 20251110 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 244500000 | USD | 20251110 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 993800000 | USD | 20260227 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 328500000 | USD | 20241112 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 796500000 | USD | 20241112 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 874900000 | USD | 20250303 | Open filing evidence |
Sales · Product Concentration Risk · Performance Brands
Concentration Risk By Benchmark · Concentration Risk By Type · Statement Business Segments
Source dimensions
us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:SalesMember;us-gaap:ConcentrationRiskByTypeAxis=us-gaap:ProductConcentrationRiskMember;us-gaap:StatementBusinessSegmentsAxis=clmt:PerformanceBrandsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-01-01 – 2026-03-31 | 88900000 | USD | 20260508 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 311000000 | USD | 20260227 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 79700000 | USD | 20251110 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 242500000 | USD | 20251110 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 80700000 | USD | 20251110 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 162800000 | USD | 20251110 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 82100000 | USD | 20260508 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 335200000 | USD | 20260227 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 80300000 | USD | 20251110 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 256100000 | USD | 20251110 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 96100000 | USD | 20251110 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 175800000 | USD | 20251110 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 79700000 | USD | 20251110 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 310300000 | USD | 20260227 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 75200000 | USD | 20241112 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 239500000 | USD | 20241112 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 303400000 | USD | 20250303 | Open filing evidence |
Sales · Product Concentration Risk · Specialty Products And Solutions
Concentration Risk By Benchmark · Concentration Risk By Type · Statement Business Segments
Source dimensions
us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:SalesMember;us-gaap:ConcentrationRiskByTypeAxis=us-gaap:ProductConcentrationRiskMember;us-gaap:StatementBusinessSegmentsAxis=clmt:SpecialtyProductsAndSolutionsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-01-01 – 2026-03-31 | 705000000 | USD | 20260508 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 2633000000 | USD | 20260227 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 679100000 | USD | 20251110 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 1957100000 | USD | 20251110 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 627900000 | USD | 20251110 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 1278000000 | USD | 20251110 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 650100000 | USD | 20260508 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 2789300000 | USD | 20260227 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 714000000 | USD | 20251110 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 2141800000 | USD | 20251110 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 746200000 | USD | 20251110 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 1427800000 | USD | 20251110 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 681600000 | USD | 20251110 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 2876900000 | USD | 20260227 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 745700000 | USD | 20241112 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 2168500000 | USD | 20241112 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 3508000000 | USD | 20250303 | Open filing evidence |
Product Concentration Risk · Revenue From Contract With Customer · Montana Renewables Segment
Concentration Risk By Type · Concentration Risk By Benchmark · Statement Business Segments
Source dimensions
us-gaap:ConcentrationRiskByTypeAxis=us-gaap:ProductConcentrationRiskMember;us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember;us-gaap:StatementBusinessSegmentsAxis=clmt:MontanaRenewablesSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-07-01 – 2026-09-30 | 518900000 | USD | 20261106 | Open filing evidence |
| 2026-01-01 – 2026-09-30 | 1083700000 | USD | 20261106 | Open filing evidence |
| 2026-04-01 – 2026-06-30 | 329000000 | USD | 20260807 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 564900000 | USD | 20260807 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 319200000 | USD | 20261106 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 898900000 | USD | 20261106 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 318000000 | USD | 20260807 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 579700000 | USD | 20260807 | Open filing evidence |
Product Concentration Risk · Revenue From Contract With Customer · Montana Renewables Segment · Other Specialty Products
Concentration Risk By Type · Concentration Risk By Benchmark · Statement Business Segments · Product Or Service
Source dimensions
us-gaap:ConcentrationRiskByTypeAxis=us-gaap:ProductConcentrationRiskMember;us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember;us-gaap:StatementBusinessSegmentsAxis=clmt:MontanaRenewablesSegmentMember;srt:ProductOrServiceAxis=clmt:OtherSpecialtyProductsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-07-01 – 2026-09-30 | 193500000 | USD | 20261106 | Open filing evidence |
| 2026-01-01 – 2026-09-30 | 432900000 | USD | 20261106 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 114800000 | USD | 20261106 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 320100000 | USD | 20261106 | Open filing evidence |
Product Concentration Risk · Revenue From Contract With Customer · Montana Renewables Segment · Renewable Fuels
Concentration Risk By Type · Concentration Risk By Benchmark · Statement Business Segments · Product Or Service
Source dimensions
us-gaap:ConcentrationRiskByTypeAxis=us-gaap:ProductConcentrationRiskMember;us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember;us-gaap:StatementBusinessSegmentsAxis=clmt:MontanaRenewablesSegmentMember;srt:ProductOrServiceAxis=clmt:RenewableFuelsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-07-01 – 2026-09-30 | 325400000 | USD | 20261106 | Open filing evidence |
| 2026-01-01 – 2026-09-30 | 650800000 | USD | 20261106 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 204400000 | USD | 20261106 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 578800000 | USD | 20261106 | Open filing evidence |
Product Concentration Risk · Revenue From Contract With Customer · Performance Brands Segment
Concentration Risk By Type · Concentration Risk By Benchmark · Statement Business Segments
Source dimensions
us-gaap:ConcentrationRiskByTypeAxis=us-gaap:ProductConcentrationRiskMember;us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember;us-gaap:StatementBusinessSegmentsAxis=clmt:PerformanceBrandsSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-07-01 – 2026-09-30 | 92800000 | USD | 20261106 | Open filing evidence |
| 2026-01-01 – 2026-09-30 | 285300000 | USD | 20261106 | Open filing evidence |
| 2026-04-01 – 2026-06-30 | 103600000 | USD | 20260807 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 192500000 | USD | 20260807 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 79700000 | USD | 20261106 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 242500000 | USD | 20261106 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 80700000 | USD | 20260807 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 162800000 | USD | 20260807 | Open filing evidence |
Product Concentration Risk · Revenue From Contract With Customer · Specialty Products And Solutions Segment
Concentration Risk By Type · Concentration Risk By Benchmark · Statement Business Segments
Source dimensions
us-gaap:ConcentrationRiskByTypeAxis=us-gaap:ProductConcentrationRiskMember;us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember;us-gaap:StatementBusinessSegmentsAxis=clmt:SpecialtyProductsAndSolutionsSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-07-01 – 2026-09-30 | 1071200000 | USD | 20261106 | Open filing evidence |
| 2026-01-01 – 2026-09-30 | 2788700000 | USD | 20261106 | Open filing evidence |
| 2026-04-01 – 2026-06-30 | 1012500000 | USD | 20260807 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 1717500000 | USD | 20260807 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 679100000 | USD | 20261106 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 1957100000 | USD | 20261106 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 627900000 | USD | 20260807 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 1278000000 | USD | 20260807 | Open filing evidence |
Product Concentration Risk · Revenue From Contract With Customer · Specialty Products And Solutions Segment · Lubricating Oils
Concentration Risk By Type · Concentration Risk By Benchmark · Statement Business Segments · Product Or Service
Source dimensions
us-gaap:ConcentrationRiskByTypeAxis=us-gaap:ProductConcentrationRiskMember;us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember;us-gaap:StatementBusinessSegmentsAxis=clmt:SpecialtyProductsAndSolutionsSegmentMember;srt:ProductOrServiceAxis=clmt:LubricatingOilsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-07-01 – 2026-09-30 | 307200000 | USD | 20261106 | Open filing evidence |
| 2026-01-01 – 2026-09-30 | 780100000 | USD | 20261106 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 183500000 | USD | 20261106 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 576000000 | USD | 20261106 | Open filing evidence |
Product Concentration Risk · Revenue From Contract With Customer · Specialty Products And Solutions Segment · Other Specialty Products
Concentration Risk By Type · Concentration Risk By Benchmark · Statement Business Segments · Product Or Service
Source dimensions
us-gaap:ConcentrationRiskByTypeAxis=us-gaap:ProductConcentrationRiskMember;us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember;us-gaap:StatementBusinessSegmentsAxis=clmt:SpecialtyProductsAndSolutionsSegmentMember;srt:ProductOrServiceAxis=clmt:OtherSpecialtyProductsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-07-01 – 2026-09-30 | 558000000 | USD | 20261106 | Open filing evidence |
| 2026-01-01 – 2026-09-30 | 1460900000 | USD | 20261106 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 360900000 | USD | 20261106 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 961800000 | USD | 20261106 | Open filing evidence |
Product Concentration Risk · Revenue From Contract With Customer · Specialty Products And Solutions Segment · Solvents
Concentration Risk By Type · Concentration Risk By Benchmark · Statement Business Segments · Product Or Service
Source dimensions
us-gaap:ConcentrationRiskByTypeAxis=us-gaap:ProductConcentrationRiskMember;us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember;us-gaap:StatementBusinessSegmentsAxis=clmt:SpecialtyProductsAndSolutionsSegmentMember;srt:ProductOrServiceAxis=clmt:SolventsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-07-01 – 2026-09-30 | 156000000 | USD | 20261106 | Open filing evidence |
| 2026-01-01 – 2026-09-30 | 417100000 | USD | 20261106 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 97700000 | USD | 20261106 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 303900000 | USD | 20261106 | Open filing evidence |
Product Concentration Risk · Revenue From Contract With Customer · Specialty Products And Solutions Segment · Waxes
Concentration Risk By Type · Concentration Risk By Benchmark · Statement Business Segments · Product Or Service
Source dimensions
us-gaap:ConcentrationRiskByTypeAxis=us-gaap:ProductConcentrationRiskMember;us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember;us-gaap:StatementBusinessSegmentsAxis=clmt:SpecialtyProductsAndSolutionsSegmentMember;srt:ProductOrServiceAxis=clmt:WaxesMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-07-01 – 2026-09-30 | 50000000 | USD | 20261106 | Open filing evidence |
| 2026-01-01 – 2026-09-30 | 130600000 | USD | 20261106 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 37000000 | USD | 20261106 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 115400000 | USD | 20261106 | Open filing evidence |
Montana Renewables Segment · Operating Segments
Statement Business Segments · Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=clmt:MontanaRenewablesSegmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-07-01 – 2026-09-30 | 518900000 | USD | 20261106 | Open filing evidence |
| 2026-01-01 – 2026-09-30 | 1083700000 | USD | 20261106 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 319200000 | USD | 20261106 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 898900000 | USD | 20261106 | Open filing evidence |
Montana Renewables Segment · Intersubsegment Eliminations · Operating Segments
Statement Business Segments · Subsegments Consolidation Items · Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=clmt:MontanaRenewablesSegmentMember;us-gaap:SubsegmentsConsolidationItemsAxis=us-gaap:IntersubsegmentEliminationsMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-07-01 – 2026-09-30 | 0 | USD | 20261106 | Open filing evidence |
| 2026-01-01 – 2026-09-30 | 0 | USD | 20261106 | Open filing evidence |
| 2026-04-01 – 2026-06-30 | 0 | USD | 20260807 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 0 | USD | 20260807 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 0 | USD | 20261106 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 0 | USD | 20261106 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 0 | USD | 20260807 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 0 | USD | 20260807 | Open filing evidence |
Montana Renewables Segment · Sales Revenue Segment · Operating Segments
Statement Business Segments · Subsegments Consolidation Items · Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=clmt:MontanaRenewablesSegmentMember;us-gaap:SubsegmentsConsolidationItemsAxis=us-gaap:SalesRevenueSegmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-07-01 – 2026-09-30 | 518900000 | USD | 20261106 | Open filing evidence |
| 2026-01-01 – 2026-09-30 | 1083700000 | USD | 20261106 | Open filing evidence |
| 2026-04-01 – 2026-06-30 | 329000000 | USD | 20260807 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 564900000 | USD | 20260807 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 319200000 | USD | 20261106 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 898900000 | USD | 20261106 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 318000000 | USD | 20260807 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 579700000 | USD | 20260807 | Open filing evidence |
Performance Brands Segment · Operating Segments
Statement Business Segments · Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=clmt:PerformanceBrandsSegmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-07-01 – 2026-09-30 | 92800000 | USD | 20261106 | Open filing evidence |
| 2026-01-01 – 2026-09-30 | 285400000 | USD | 20261106 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 79900000 | USD | 20261106 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 242800000 | USD | 20261106 | Open filing evidence |
Performance Brands Segment · Intersubsegment Eliminations · Operating Segments
Statement Business Segments · Subsegments Consolidation Items · Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=clmt:PerformanceBrandsSegmentMember;us-gaap:SubsegmentsConsolidationItemsAxis=us-gaap:IntersubsegmentEliminationsMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-07-01 – 2026-09-30 | 0 | USD | 20261106 | Open filing evidence |
| 2026-01-01 – 2026-09-30 | 100000 | USD | 20261106 | Open filing evidence |
| 2026-04-01 – 2026-06-30 | 0 | USD | 20260807 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 100000 | USD | 20260807 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 200000 | USD | 20261106 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 300000 | USD | 20261106 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 100000 | USD | 20260807 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 100000 | USD | 20260807 | Open filing evidence |
Performance Brands Segment · Sales Revenue Segment · Operating Segments
Statement Business Segments · Subsegments Consolidation Items · Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=clmt:PerformanceBrandsSegmentMember;us-gaap:SubsegmentsConsolidationItemsAxis=us-gaap:SalesRevenueSegmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-07-01 – 2026-09-30 | 92800000 | USD | 20261106 | Open filing evidence |
| 2026-01-01 – 2026-09-30 | 285300000 | USD | 20261106 | Open filing evidence |
| 2026-04-01 – 2026-06-30 | 103600000 | USD | 20260807 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 192500000 | USD | 20260807 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 79700000 | USD | 20261106 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 242500000 | USD | 20261106 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 80700000 | USD | 20260807 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 162800000 | USD | 20260807 | Open filing evidence |
Specialty Products And Solutions Segment · Operating Segments
Statement Business Segments · Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=clmt:SpecialtyProductsAndSolutionsSegmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-07-01 – 2026-09-30 | 1084400000 | USD | 20261106 | Open filing evidence |
| 2026-01-01 – 2026-09-30 | 2814800000 | USD | 20261106 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 684100000 | USD | 20261106 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 1972000000 | USD | 20261106 | Open filing evidence |
Specialty Products And Solutions Segment · Intersubsegment Eliminations · Operating Segments
Statement Business Segments · Subsegments Consolidation Items · Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=clmt:SpecialtyProductsAndSolutionsSegmentMember;us-gaap:SubsegmentsConsolidationItemsAxis=us-gaap:IntersubsegmentEliminationsMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-07-01 – 2026-09-30 | 13200000 | USD | 20261106 | Open filing evidence |
| 2026-01-01 – 2026-09-30 | 26100000 | USD | 20261106 | Open filing evidence |
| 2026-04-01 – 2026-06-30 | 9000000 | USD | 20260807 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 12900000 | USD | 20260807 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 5000000 | USD | 20261106 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 14900000 | USD | 20261106 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 5100000 | USD | 20260807 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 9900000 | USD | 20260807 | Open filing evidence |
Specialty Products And Solutions Segment · Sales Revenue Segment · Operating Segments
Statement Business Segments · Subsegments Consolidation Items · Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=clmt:SpecialtyProductsAndSolutionsSegmentMember;us-gaap:SubsegmentsConsolidationItemsAxis=us-gaap:SalesRevenueSegmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-07-01 – 2026-09-30 | 1071200000 | USD | 20261106 | Open filing evidence |
| 2026-01-01 – 2026-09-30 | 2788700000 | USD | 20261106 | Open filing evidence |
| 2026-04-01 – 2026-06-30 | 1012500000 | USD | 20260807 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 1717500000 | USD | 20260807 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 679100000 | USD | 20261106 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 1957100000 | USD | 20261106 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 627900000 | USD | 20260807 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 1278000000 | USD | 20260807 | Open filing evidence |